Multi-licensed UK and EU medical cannabis importer and distributor seeks strategic equity partner!
Uniquely-licensed supplier of exclusive, high-quality, cost-effective branded cannabis products via established medical clinic partnerships & UK pharmacy contracts. Poised for significant expansion in the UK and EU medical cannabis sectors!
Listing ID:
16111269447
Licence(s) Held:
• UK: Import & Distribution (MHRA issued), Schedule 1 & 2 Narcotics (Home Office issued), Processing (MHRA issued), Online Medical Clinics (Partner)
• Channel Island: Cultivation (BGCA & HO In Process), Processing (BCGA issued)
Seeking strategic equity partner to invest £5.5 million (approximately $7 million USD as of July 2025) to 10x sales
Listing Details:
Phase 1: UK Market Dominance
Continued import and distribution of high-quality, cost-effective, branded cannabis flower and oil products for UK medical cannabis patients via established UK pharmacy contracts and new clinic and private hospital partnerships.
Exclusive relationships with top-ranked Canadian producers for a custom product line.
Strong customer satisfaction with products ranking #1 on UK Reddit and a nomination for Producer of the Year Cannabis Europa.
Rapid revenue growth with 900% increase since August 2024.
Projected UK sales of £2-3 million/month supported by scale-up.
Development and sale of new readily consumable product forms.
Experienced, industry-leading international team with deep expertise in navigating global medical cannabis markets.
Existing sales of £900K/month in 2025, with plans to grow to £2M/month in 2026 and £3M/month in 2027.
Phase 2: EU Market Expansion
Unlock international distribution with a new UK/Guernsey Distribution Hub for the EU, leveraging a tax-friendly jurisdiction to speed up cross-border logistics and position the company as a licensed importer into major EU markets.
Projected EU revenue of £50 million in 5 years from the new Guernsey facility and expanded distribution.
Expansion of wholesale distribution of branded cannabis flower, oils, and derivative products to European Union markets.
Focus on driving down Cost of Goods Sold (COGS) through cash purchases and GACP Direct importing.
Add new co-packing revenue streams.
Key Barriers to Entry:
Scarce licensing.
Established relationships with suppliers.
Unique relationships with customers and patients.
16111269447
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
18925796406
Established Alberta cannabis brand with 18 AGLC-Approved SKUs & 6,000 Sq. Ft. cultivation and processing facility – $350K Asset Sale
An operating cannabis brand in Northern Alberta — 40 minutes from the AGLC warehouse — with 18 AGLC-approved SKUs, and a 6,000 sq ft licensed facility, available as a $350,000 asset sale of brand, inventory, and lease.
6891632282
Turnkey, EU GMP & GACP-Certified Canadian Medical Cannabis Producer & International Export Hub for Sale
Rare opportunity to acquire a profitable, fully licensed, EU-GMP certified Canadian medical cannabis producer with international export access. One of fewer than 12 EU-GMP certifications among 800+ Canadian LPs.
3433737347
Turnkey, GACP & CUMCS-Certified 54,000 sq. ft. Cannabis Infrastructure & International Export Hub in Montreal, QC for Sale!
A rare opportunity to acquire a fully licensed, debt-free cannabis enterprise in QC with $11.5M in 2025 revenue, dual international export certifications, and turnkey access to the Quebec market. The sale includes all Health Canada licences, brand IP, equipment, and leasehold operational infrastructure.